Nuclear Medicine: Page 246

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

November 21, 2010

Big cumulative doses seen at cardiac SPECT MPI

By Eric Barnes

Patients undergoing SPECT myocardial perfusion imaging (MPI) receive high cumulative radiation doses and often undergo repeat scans with the modality, concludes a study of more than 1,000 patients published online November 15 in the Journal of the American Medical Association.

November 21, 2010

Global PET/SPECT market could reach $10.3B

By AuntMinnie.com staff writers

Powered by transparent reimbursement policies, new emerging economies, novel applications such as Alzheimer's detection, and expanding oncology applications, the global PET market could reach about $6.3 billion this year.

November 18, 2010

Siemens to unveil Biograph mMR PET/MRI scanner at RSNA

By Wayne Forrest

Multimodality vendor Siemens Healthcare of Malvern, PA, plans to take the next step into hybrid imaging with the launch of Biograph mMR, a new integrated PET/MRI scanner, later this month at the RSNA meeting in Chicago.

November 18, 2010

Siemens wins U.K. PET/CT contract

By AuntMinnie.com staff writers

Siemens Healthcare of Erlangen, Germany, has won a U.K. installation of its hybrid PET/CT unit.

November 16, 2010

NCI awards UCLA $10M molecular grant

By AuntMinnie.com staff writers

The U.S. National Cancer Institute (NCI) has renewed a five-year, $10 million grant to the University of California, Los Angeles (UCLA) for its molecular imaging center.

November 15, 2010

IsoRay Q1 sales dip by 4%

By AuntMinnie.com staff writers

Product sales decreased slightly for medical isotope developer IsoRay Medical in the company's first quarter of its 2011 fiscal year.

November 15, 2010

Road to RSNA 2010: Molecular Imaging Preview

By Wayne Forrest

Hybrid anatomical/functional imaging, the role of FDG, and the development of new molecular imaging agents will be among the overriding themes in nuclear medicine and molecular imaging at this year's RSNA meeting in Chicago.

November 15, 2010

FDG-PET/CT contributes to the diagnosis of tuberculosis-induced inflammation

By Wayne Forrest

Thursday, December 2 | 11:20 a.m.-11:30 a.m. | SSQ15-06 | Room S505ABGerman researchers have found that FDG-PET/CT may contribute to the diagnosis of tuberculosis-induced intraocular inflammation, especially in the case of latent and asymptomatic infection.

November 15, 2010

FDG-PET/CT aids evaluation of bladder cancer patients

By Wayne Forrest

Wednesday, December 1 | 3:30 p.m.-3:40 p.m. | SSM18-04 | Room S505ABFDG-PET/CT is helpful in accurately assessing disease and can provide significant prognostic information in patients with urothelial cancer. So concluded researchers from Johns Hopkins University in Baltimore in their study scheduled to be presented Wednesday afternoon at RSNA 2010.

November 15, 2010

F-18 NaF boosts sensitivity to detect malignancies with FDG-PET/CT

By Wayne Forrest

Wednesday, December 1 | 11:20 a.m.-11:30 a.m. | SSK13-06 | Room S505ABOn Wednesday morning, researchers from Stanford University in Stanford, CA, will show preliminary study results that "strongly suggest" dual-tracer PET/CT imaging with FDG and F-18 sodium fluoride (F-18 NaF) increases the sensitivity of detecting malignancy compared to FDG alone.

November 15, 2010

FDG-PET can help with early tumor detection in Li-Fraumeni syndrome

By Wayne Forrest

Wednesday, December 1 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABResearchers in Brazil have found that PET/CT can be a useful clinical tool for detecting unknown and early-stage cancer sites in high-risk asymptomatic patients with Li-Fraumeni syndrome.

November 15, 2010

Previous Page

Page 246 of 440

Next Page